Why the study?
C-reactive protein apheresis may preserve myocardial tissue after acute myocardial infarction with delayed revascularization.
Is C-reactive protein (CRP) apheresis safe and well-tolerated in patients with cardiogenic shock following acute myocardial infarction?
Is C-reactive protein (CRP) apheresis safe and well-tolerated in patients with cardiogenic shock following acute myocardial infarction?
CRP apheresis appears to be well-tolerated and associated with favorable discharge outcomes in a small series of patients with cardiogenic shock complicating acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
CRP apheresis feasible in post-MI shock; leaves open myocardial preservation, warranting prospective trials.
Torzewski et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: